Clinical trial
A Randomized, Open Label, Paralel Goup Study To Assess With A Non- Inferiority Hypothesis The Efficacy And Safety Of The Medical Device Iracross (Crosslinked 2% Hyaluronic Acid) Versus The Medical Device Iraline (Linear 2% Hyaluronic Acid), Administered Intra-Articular To Patients With Knee Osteoarthritis
NCT04574453 is registered in ClinicalTrials.gov with I.R.A. Istituto Ricerche Applicate S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open Label, Paralel Goup Study To Assess With A Non- Inferiority Hypothesis The Efficacy And Safety Of The Medical Device Iracross (Crosslinked 2% Hyaluronic Acid) Versus The Medical Device Iraline (Linear 2% Hyaluronic Acid), Administered Intra-Articular To Patients With Knee Osteoarthritis
- Lead sponsor
- I.R.A. Istituto Ricerche Applicate S.p.A.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 29, 2020
- Completion date
- February 10, 2021
- Enrollment
- 103 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.